• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Unspecified (PubMed=2216456).
  

PubMed=2486618
Kunishige Kato, Hisatake Ikeda, Yoshihiro Akiyama, Junko Suda, Mitsuoki Eguchi, Toshiharu Furukawa;
Establishment and characterization of human rhabdomyosarcoma cell line (RMS).
Hum. Cell 2:214-215(1989)

PubMed=2216456
Michael Rudolf Stratton, Sandra Moss, William Warren, Helen Patterson, Jeremy Clark, Cyril Fisher, Christopher David Marsden Fletcher, Adrian B.S. Ball, Meirion Thomas, Barry Austin Gusterson, Colin S. Cooper;
Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
Oncogene 5:1297-1301(1990)

PubMed=18082704; DOI=10.1016/j.jpedsurg.2007.08.026
Hiroaki Komuro, Ryoko Saihara, Miki Shinya, Junko Takita, Setsuko Kaneko, Michio Kaneko, Yasuhide Hayashi;
Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines.
J. Pediatr. Surg. 42:2040-2045(2007)

PubMed=19235922; DOI=10.1002/gcc.20655
Edoardo Missiaglia, Joanna Selfe, Mohamed Hamdi, Daniel Williamson, Gerben Schaaf, Cheng Fang, Jan Koster, Brenda M. Summersgill, Boo Messahel, Rogier Versteeg, Kathryn Pritchard-Jones ...Show all 13 authors... , Marcel Kool, Janet M. Shipley; Show fewer authors
Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
Genes Chromosomes Cancer 48:455-467(2009)

PubMed=23578105; DOI=10.1111/cas.12173; PMCID=PMC7657110
Riki Nishimura, Junko Takita, Aiko Sato-Otsubo, Motohiro Kato, Katsuyoshi Koh, Ryoji Hanada, Yukichi Tanaka, Keisuke Kato, Daichi Maeda, Masashi Fukayama, Masashi Sanada ...Show all 13 authors... , Yasuhide Hayashi, Seishi Ogawa; Show fewer authors
Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array.
Cancer Sci. 104:856-864(2013)

PubMed=23665679; DOI=10.1038/onc.2013.129
Elizabeth I. Sokolowski, Claire B. Turina, Ken Kikuchi, David M. Langenau, Charles Keller;
Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.
Oncogene 33:1877-1889(2014)

PubMed=36768928; DOI=10.3390/ijms24032601; PMCID=PMC9917031
Andrea Timpanaro, Caroline Piccand, Anne-Christine Uldry, Peter-Karl Bode, Dzhangar Dzhumashev, Rita Sala, Manfred Heller, Jochen Rossler, Michele Bernasconi;
Surfaceome profiling of cell lines and patient-derived xenografts confirm FGFR4, NCAM1, CD276, and highlight AGRL2, JAM3, and L1CAM as surface targets for rhabdomyosarcoma.
Int. J. Mol. Sci. 24:2601.1-2601.28(2023)